 efficaci ic novel receptor antagonist prevent migrain attack complex answer simpl question ic migrain studi group novel potent select receptor antagonist ic migrain attack random double-blind placebo-control multicentr intern trial total patient classic common migrain trial parallel-group design month baselin observ month treatment similar result primari efficaci paramet proport reduct attack frequenc month treatment twenty-two patient trial efficaci mild constip patient activ treatment none dose ic mg mg mg result attack frequenc placebo confid interv differ effect placebo wide mg ic reduct attack frequenc unusu find efficaci paramet result dose mg result dose mg intermedi effect mg invers relat dose efficaci bell-shap dose-respons curv mg effect present studi inconclus intrigu result dose definit conclus efficaci ic prophylact treatment migrain